Astro-Med, Inc. (ALOT) - 10-K Summary
Business Context and Reporting Period
Company: Astro-Med, Inc.
Filing Type: Form 10-K (Annual Report)
Period Ended: January 31, 2007
Business Overview: Astro-Med designs, develops, manufactures, and distributes specialty printers and electronic instruments for data acquisition, analysis, and presentation. Operations are organized into three segments: Test & Measurement (T&M), QuickLabel Systems (label printing), and Grass Technologies (GT, neurological instrumentation). The company serves aerospace, automotive, life sciences, and general manufacturing markets globally.
Key Financial Metrics
| Metric (in thousands) | Fiscal 2007 | Fiscal 2006 |
|---|---|---|
| Net Sales | $65,519 | $59,301 |
| Gross Profit | $26,998 | $24,658 |
| Gross Margin | 41.2% | 41.6% |
| Operating Income | $8,741 | $3,155 |
| Net Income | $6,059 | $2,551 |
| Diluted EPS | $0.82 | $0.35 |
| Operating Cash Flow | $2,383 | $2,407 |
| Total Assets | $58,001 | $49,647 |
| Working Capital | $34,294 | $31,222 |
| Long-Term Debt | $0 | $0 |
Note: Fiscal 2007 results include a significant non-recurring gain on the sale of real estate.
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 10.5% to $65.5 million, driven by a 36.9% surge in the T&M segment (specifically Everest and Ruggedized products) and steady growth in QuickLabel consumables.
- Profitability Spike: Net income more than doubled to $6.1 million. This was primarily due to a $5.25 million pre-tax gain from the sale of the Braintree, MA facility. Excluding this gain, operating income grew organically due to volume increases.
- Margin Compression: Gross margin decreased slightly from 41.6% to 41.2% due to higher manufacturing costs associated with ROHS and FAA compliance, offsetting productivity gains.
- Segment Performance:
- T&M: Sales up 36.9%; Operating profit improved from $331k to $2.6M.
- QuickLabel: Sales up 4.8%; Operating profit declined to $1.2M from $2.9M due to a shift in mix toward lower-margin consumables and higher support costs.
- Grass Technologies: Sales up 3.1%; Operating profit increased to $3.1M.
Guidance, Outlook, and Risks
Management Commentary & Strategy:
- The company plans to sustain growth by increasing investment in personnel, plant capacity (purchasing the Rockland, MA facility), and manufacturing equipment.
- Research and Development (R&D) spending remains stable at approximately 6.4% of sales ($4.2M).
- Dividends were increased to $0.20 per share for fiscal 2007.
Risks and Contingencies:
- Competition: Highly competitive markets with rapid technological changes and potential new entrants.
- Supply Chain: Reliance on sole-source suppliers for certain components could lead to delays or price increases.
- International Exposure: Approximately 27.5% of sales are international, exposing the company to currency fluctuations and foreign economic conditions.
- Product Liability: Potential liabilities from installed product failures or design defects.
Unusual Items:
- Real Estate Transaction: Sale of Braintree property generated a $5.25M net gain. Proceeds were used to purchase a new facility in Rockland, MA, as part of a Section 1031 like-kind exchange.
- Accounting Change: Adoption of SFAS No. 123(R) for share-based compensation resulted in a $413k reduction in pre-tax income.
Investor Verification Checklist
- Recurring Earnings: Verify organic earnings growth by excluding the $5.25M one-time real estate gain from the 2007 net income calculation.
- QuickLabel Margins: Investigate the decline in QuickLabel operating profit despite sales growth; confirm if the shift to consumables is a permanent structural change.
- Real Estate Strategy: Confirm the operational benefits and cost implications of the new Rockland, MA facility purchase.
- Debt Capacity: Note the company has no long-term debt but maintains a $3.5M unsecured line of credit.
- Stock Repurchases: Review the remaining authorization for share buybacks (447,589 shares authorized as of Jan 31, 2007).